6-Deoxy Penciclovir

6-Deoxy Penciclovir

SCHEMBL660970

Nc1ncc2ncn(CCC(CO)CO)c2n1

nearest known ligand 0.66

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.66
KDM4E B2RXH2 1/20 0.66
HPGD P15428 1/20 0.66
ADRA1A P35348 1/20 0.66
HSD17B10 Q99714 1/20 0.66
RXFP1 Q9HBX9 1/20 0.66
HDAC6 Q9UBN7 2/20 0.45
HSP90AA1 P07900 1/20 0.41
HSP90AB1 P08238 1/20 0.41
RPS6KA3 P51812 1/20 0.40
SRC P12931 1/20 0.38
CCNE1 P24864 4/20 0.34
CDK2 P24941 4/20 0.34
CDK1 P06493 3/20 0.34
CCNB1 P14635 3/20 0.34
ADORA2A P29274 2/20 0.33
TK1 P04183 1/20 0.33
ADORA1 P30542 1/20 0.33
CYP2C19 P33261 1/20 0.33
FDPS P14324 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
6-Deoxy Penciclovir SCHEMBL29797811 1.00 ALDH1A1 (0.66) ALDH1A1KDM4EHPGDADRA1AHSD17B10
6-Deoxy Penciclovir SCHEMBL3324010 0.99 ALDH1A1 (0.65) ALDH1A1KDM4EHPGDADRA1AHSD17B10
SCHEMBL10711562 0.93 KDM4E (0.62) ALDH1A1KDM4EHPGDADRA1AHSD17B10
6-Deoxy Penciclovir SCHEMBL4207112 0.92 KDM4E (0.71) ALDH1A1KDM4EHPGDADRA1AHSD17B10
SCHEMBL9763803 0.87 KDM4E (0.58) ALDH1A1KDM4EHPGDADRA1AHSD17B10
SCHEMBL9763808 0.87 KDM4E (0.58) ALDH1A1KDM4EHPGDADRA1AHSD17B10
SCHEMBL19242423 0.86 KDM4E (0.60) ALDH1A1KDM4EHPGDADRA1AHSD17B10
Detiviciclovir SCHEMBL7744996 0.85 KDM4E (0.52) ALDH1A1KDM4EHPGDADRA1AHSD17B10
SCHEMBL1875480 0.85 KDM4E (0.62) ALDH1A1KDM4EHPGDADRA1AHSD17B10
Monoacetyl-6-Deoxy Penciclovir SCHEMBL1878763 0.85 KDM4E (0.89) ALDH1A1KDM4EHPGDADRA1AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 197 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9549930-B2 Combined systemic and topical treatment of disordered and/or prodromal stage tissue QUADEX PHARMACEUTICALS, LLC (US) 2017-01-24 US claimed
US-9545408-B2 Combined systemic and topical treatment of disordered tissues QUADEX PHARMACEUTICALS, INC. (US) 2017-01-17 US claimed
US-7148349-B2 Cyclic phosphate diesters of 1,3-propane-1-aryl diols and their use in preparing prodrugs METABASIS THERAPEUTICS, INC. (US) 2006-12-12 US claimed
US-5250688-A Treating herpes virus infections BEECHAM GROUP P.L.C. (GB) 1993-10-05 US claimed
EP-0182024-B1 PURINE DERIVATIVES AND THEIR PHARMACEUTICAL USE BEECHAM GROUP PLC (GB) 1991-04-03 EP claimed
EP-0186640-B1 DERIVATIVES OF PURINE, PROCESS FOR THEIR PREPARATION AND A PHARMACEUTICAL PREPARATION Medivir Aktiebolag (SE) 1990-02-07 EP claimed
WO-1987005604-A1 2-AMINOPURINE DERIVATIVES AND PROCESS FOR THEIR PREPARATION BEECHAM GROUP P.L.C. (GB) 1987-09-24 WO claimed
EP-0186640-A1 Derivatives of purine, process for their preparation and a pharmaceutical preparation Medivir Aktiebolag (SE) 1986-07-02 EP claimed
EP-0182024-A2 Purine derivatives and their pharmaceutical use BEECHAM GROUP PLC (GB) 1986-05-28 EP claimed
JP-6025241-A None JP disclosed
CN-112979653-A Method for synthesizing famciclovir by using microchannel reactor 上药康丽(常州)药业有限公司 2021-06-18 CN disclosed
EP-3692015-A1 NOVEL GLUTAMINE ANTAGONISTS AND USES THEREOF The John Hopkins University (US) 2020-08-12 EP disclosed
WO-2019071110-A1 NOVEL GLUTAMINE ANTAGONISTS AND USES THEREOF THE JOHN HOPKINS UNIVERSITY (US) 2019-04-11 WO disclosed
US-10080785-B2 Albumin fusion proteins NOVOZYMES BIOPHARMA DK A/S (DK) 2018-09-25 US disclosed
US-5036071-A Herper virus MEDIVIR AB (SE) 1991-07-30 US disclosed
EP-0182024-B1 PURINE DERIVATIVES AND THEIR PHARMACEUTICAL USE BEECHAM GROUP PLC (GB) 1991-04-03 EP disclosed
EP-0186640-B1 DERIVATIVES OF PURINE, PROCESS FOR THEIR PREPARATION AND A PHARMACEUTICAL PREPARATION Medivir Aktiebolag (SE) 1990-02-07 EP disclosed
EP-0302644-A2 Purine compounds and their preparation BEECHAM GROUP PLC (GB) 1989-02-08 EP disclosed
WO-1987005604-A1 2-AMINOPURINE DERIVATIVES AND PROCESS FOR THEIR PREPARATION BEECHAM GROUP P.L.C. (GB) 1987-09-24 WO disclosed
EP-0182024-A2 Purine derivatives and their pharmaceutical use BEECHAM GROUP PLC (GB) 1986-05-28 EP disclosed